Clarify Health Buys Apervita’s Value Optimization Business
Clarify Health, a cloud analytics company focused on healthcare and life sciences organizations, has purchased the Value Optimization business of Apervita, a platform for healthcare collaboration for payers, providers and other stakeholders.
San Francisco-based Clarify said the acquisition, for an undisclosed price, would bolster its integrated analytics platform for end-to-end value-based contract design, payments reconciliation, clinical performance assessment, and reporting.
The Unified Value Platform is powered by the big-data capabilities of the financial services industry and the analytics methodologies of Wins Above Replacement (WAR) in baseball, Clarify said.
“Our health plan and value-based customers’ needs are increasingly complex, driven by intricate analytics requirements across multiple provider contract types. A trusted platform that can objectively and transparently analyze data from plans and providers is a foundational enabler to the success of new payment models. We are excited to welcome an experienced team that will further accelerate Clarify’s delivery of innovative payments and clinical improvement solutions,” said Jean Drouin, M.D., CEO of Clarify Health, in a statement.
The acquisition of Apervita’s Value Optimization business comes on the heels of Clarify Health’s $115 million Series C funding led by Insight Partners.
“This deal reaffirms Clarify’s deliberate strategy to combine healthcare expertise with the latest technologies from other industries to create novel solutions that empower healthcare organizations to deliver better care and therapies,” said Todd Gottula, president of Clarify Health, in a statement. “Our engineering and development teams are excited to offer healthcare organizations the full flexibility, precision and automation of payments capabilities more traditionally associated with financial services, the industry from where many of Clarify’s core engineers originate.”
Apervita said it would continue to focus on providing solutions to support the industry’s transformation to digital quality measures and the rollout of clinical intelligence solutions that inform decision making at the point of care and can improve performance against those quality measures. This focus will enable Apervita to help health organizations address two trends in the marketplace. First, regulatory bodies like the Centers for Medicare and Medicaid Services (CMS) and National Committee for Quality Assurance (NCQA) have accelerated the transition to all digital quality measurements by 2025. Second, the pandemic made evident the need to support providers with real-time clinical insights and best-practice guidelines. Currently, more than 3,500 hospitals use Apervita’s Quality Measurement Solutions through a strategic partnership with The Joint Commission.
Apervita said it would continue to transform quality measurement and care delivery by providing new capabilities to payers and providers, and enabling the learning health system, a framework that drives better outcomes and cost efficiencies across the health ecosystem.
